These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2021959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
    Burel-Vandenbos F, Benchetrit M, Miquel C, Fontaine D, Auvergne R, Lebrun-Frenay C, Cardot-Leccia N, Michiels JF, Paquis-Flucklinger V, Virolle T.
    J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
    [Abstract] [Full Text] [Related]

  • 5. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G.
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [Abstract] [Full Text] [Related]

  • 6. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W, Slagle B, Gibo DM, Powers SK, Gillespie GY.
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [Abstract] [Full Text] [Related]

  • 7. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB, Haugland HK, Bjerkvig R.
    Invasion Metastasis; 1997 Apr; 17(5):270-80. PubMed ID: 9876221
    [Abstract] [Full Text] [Related]

  • 9. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification.
    Muracciole X, Romain S, Dufour H, Palmari J, Chinot O, Ouafik L, Grisoli F, Branger DF, Martin PM.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):592-8. PubMed ID: 11849778
    [Abstract] [Full Text] [Related]

  • 10. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
    Waha A, Baumann A, Wolf HK, Fimmers R, Neumann J, Kindermann D, Astrahantseff K, Blümcke I, von Deimling A, Schlegel U.
    J Neurosurg; 1996 Oct 01; 85(4):634-41. PubMed ID: 8814167
    [Abstract] [Full Text] [Related]

  • 11. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.
    Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B.
    J Neurol; 1995 Oct 01; 242(10):683-8. PubMed ID: 8568531
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies to malignant human gliomas.
    Wikstrand CJ, Fredman P, Svennerholm L, Humphrey PA, Bigner SH, Bigner DD.
    Mol Chem Neuropathol; 1992 Oct 01; 17(2):137-46. PubMed ID: 1384525
    [Abstract] [Full Text] [Related]

  • 13. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.
    Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP.
    Cancer Res; 1991 Apr 15; 51(8):2164-72. PubMed ID: 2009534
    [Abstract] [Full Text] [Related]

  • 14. The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein.
    Hoi Sang U, Espiritu OD, Kelley PY, Klauber MR, Hatton JD.
    J Neurosurg; 1995 May 15; 82(5):847-57. PubMed ID: 7714612
    [Abstract] [Full Text] [Related]

  • 15. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.
    Cancer Res; 2002 Jun 01; 62(11):3159-66. PubMed ID: 12036929
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
    Andersson U, Guo D, Malmer B, Bergenheim AT, Brännström T, Hedman H, Henriksson R.
    Acta Neuropathol; 2004 Aug 01; 108(2):135-42. PubMed ID: 15148612
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D, Pedone C.
    Neuro Oncol; 2000 Apr 01; 2(2):71-9. PubMed ID: 11303623
    [Abstract] [Full Text] [Related]

  • 18. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E.
    Br J Cancer; 1997 Apr 01; 75(9):1269-78. PubMed ID: 9155045
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor gene expression in high grade gliomas.
    Larysz D, Kula D, Kowal M, Rudnik A, Jarząb M, Blamek S, Bierzyńska-Macyszyn G, Kowalska M, Bażowski P, Jarząb B.
    Folia Neuropathol; 2011 Apr 01; 49(1):28-38. PubMed ID: 21455841
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.